Utility of Syndromic Surveillance Using Novel Clinical Data Sources

Authors

  • Rebecca Zwickl International Society for Disease Surveillance
  • Charles Ishikawa International Society for Disease Surveillance
  • Laura C. Streichert International Society for Disease Surveillance

DOI:

https://doi.org/10.5210/ojphi.v5i1.4488

Abstract

Discusses the current state of syndromic surveillance using inpatient and ambulatory clinical data in the United States and the potential utility of the data. The Meaningful Use Stages 2 and 3 regulations incentivize the use of these data sources. Existing systems effectively perform a range of activities from influenza-like illness surveillance to heart disease risk factor surveillance. With further development, ambulatory and inpatient data could become an integral part of syndromic surveillance practice.

Author Biography

Rebecca Zwickl, International Society for Disease Surveillance

Rebecca Zwickl, MPH, is a Public Health Analyst at ISDS and played a key role in coordinating the development of the recommendations from the ISDS Meaningful Use Workgroup. She previously worked as an emergency preparedness consultant providing support services to health departments in the Boston area. Rebecca holds an MPH in Epidemiology and Health Policy and Management from Boston University's School of Public Health and a BA from the University of Michigan.

Downloads

Published

2013-03-24

How to Cite

Zwickl, R., Ishikawa, C., & Streichert, L. C. (2013). Utility of Syndromic Surveillance Using Novel Clinical Data Sources. Online Journal of Public Health Informatics, 5(1). https://doi.org/10.5210/ojphi.v5i1.4488

Issue

Section

Oral Presentations: Electronic Health Records